We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Vivomedica | LSE:VVM | London | Ordinary Share | GB0030475106 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.10 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:9273J
Vivomedica PLC
14 December 2007
VivoMedica plc (the "Company")
14 December 2007
Director Shareholding
The Company announces that it received notification yesterday that on 13
December 2007 Ms Susan Veness, the Finance Director of the Company, bought
100,000 Ordinary Shares of 2 pence per share at a price of 1 pence per share.
Following this notification she has an interest in 100,000 shares representing
0.05% of the issued share capital of the Company.
The Company also announces that it received notification yesterday that on 11
December 2007 Mr Alan Edwards, a Non Executive Director of the Company, bought
100,000 ordinary shares of 2 pence each in the Company at a price of 1 pence per
share and on 12 December 2007 he bought an additional 90,000 ordinary shares of
2 pence each in the Company at a price of 2 cents per share.
Following this notification he has an interest in 190,000 ordinary shares
representing 0.95% of the issued share capital of the Company.
The Company also announces that it received notification yesterday that on
11 December 2007 Mr Peter Leyland, the Chief Executive Officer of the Company,
bought 250,000 Ordinary Shares of 2 pence per share at a price of 0.75 pence per
share.
Following this notification he has an interest in 450,000 shares representing
0.22% of the issued share capital of the Company.
ENDS.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSTIBLTMMBBMBR
1 Year Vivomedica Chart |
1 Month Vivomedica Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
